Example: Heart Attack

Search clinical trials for: Tetrabenazine

Total 20 results

    • NCT02509793
      Recruiting
      A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
      Conditions: Huntington's Disease
    • NCT03702855
      Completed
      Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions
      Conditions: Healthy
    • NCT03696329
      Completed
      Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions
      Conditions: Healthy
    • NCT01834911
      Completed
      Effect of Tetrabenazine on Stroop Interference in HD
      Conditions: Huntington Disease
    • NCT01543321
      Completed
      Xenazine in Late Dyskinetic Syndrome With Neuroleptics
      Conditions: Tardive Dyskinesia
    • NCT01133353
      Withdrawn
      A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
      Conditions: Tourette's Syndrome
    • NCT00362804
      Completed
      Tetrabenazine for Partial Responders
      Conditions: Schizophrenia; Schizoaffective Disorder
    • NCT00642057
      Available
      Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
      Conditions: Hyperkinetic Movement Disorders
    • NCT00219804
      Completed
      Efficacy and Safety of Tetrabenazine in Chorea
      Conditions: Huntington's Disease
    • NCT00632645
      Completed
      Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
      Conditions: Huntington Disease
    • NCT04523935
      Completed
      Management of Excessive Crying in Cerebral Palsy
      Conditions: Cerebral Palsy; Crying
    • NCT01451463
      Completed
      Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
      Conditions: Huntington's Disease
    • NCT04301726
      Not yet recruiting
      Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD
      Conditions: Huntington Disease
    • NCT01733121
      Completed
      NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
      Conditions: Tardive Dyskinesia
    • NCT01688037
      Completed
      NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
      Conditions: Tardive Dyskinesia
    • NCT01393600
      Completed
      NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
      Conditions: Tardive Dyskinesia
    • NCT01795859
      Completed
      First Time Use of SD-809 in Huntington Disease
      Conditions: Chorea
    • NCT02582736
      Completed
      Antipsychotics and Risk of Hyperglycemic Emergencies
      Conditions: Psychotic Disorders; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Diabetes Mellitus, Type 2
    • NCT01897896
      Completed
      Alternatives for Reducing Chorea in Huntington Disease
      Conditions: Chorea Associated With Huntington Disease
    • NCT02191358
      Completed
      YouScript IMPACT Registry
      Conditions: Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations